Table 1.

Outcomes which were reported

Studies	Adverse outcomes	Follow-up period
Berger (2008) [11]	Death	2 years
Lemesle (2016) [12]	Composite endpoints, all-cause death, cardiac death, MI, stroke, BARC type ≥ 3 bleeding	2 years
Park (2016) [13]	Composite endpoints, all-cause death, cardiac death, MI, stroke, BARC type ≥ 3 bleeding	3 years

MI myocardial infarction, BARC bleeding according to the Bleeding Academic Research Consortium; composite outcomes include: cardiovascular death, MI and stroke